A Competitive Ligand-binding Assay for the Detection of Neutralizing Antibodies Against XTMAB-16

Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with acceptable drug and target tolerances to guide future clinical trials.

Thank you for registering!

You now have the option of downloading the resource or viewing the web version below.